Recurrent respiratory tract infections in pediatric age: A population-based survey of the therapeutic role of macrolides

Nicola Principi, S. Esposito, R. Cavagna, S. Bosis, R. Droghetti, N. Faelli, S. Tosi, E. Begliatti, Giorgio Amato, Lucio Armenio, Luigi Chetrì, Filippo Bernardi, Ilaria Corsini, Mario Berni Canani, Attilio Boner, Ammon Cohen, Domenico De Mattia, Federico Schettini, Francesco Paone, Franca ParizziCarmelo Salpietro, Silvana Bruglia, Alberto Vierucci, Chiara Azzari

Research output: Contribution to journalArticlepeer-review

Abstract

In order to evaluate the efficacy of macrolides in pediatric patients with recurrent respiratory tract infections (RRTIs), we enrolled 1,706 children (783 females) aged between 6 months and 14 years (median: 4 years) with an acute respiratory infection and a history of RRTIs (≥8 episodes per year if aged

Original languageEnglish
Pages (from-to)53-59
Number of pages7
JournalJournal of Chemotherapy
Volume15
Issue number1
Publication statusPublished - Feb 2003

Keywords

  • Antibacterials
  • Children
  • Macrolides
  • Pediatric age
  • Recurrent respiratory tract infections

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Microbiology (medical)

Fingerprint Dive into the research topics of 'Recurrent respiratory tract infections in pediatric age: A population-based survey of the therapeutic role of macrolides'. Together they form a unique fingerprint.

Cite this